Lv1
20 积分 2022-02-16 加入
[The current status and optimization strategies of CAR-T cell therapy in hematological malignancies]
2天前
已完结
C‐CAR066, a novel fully human anti‐CD20 CAR‐T therapy for relapsed or refractory large B‐cell lymphoma after failure of anti‐CD19 CAR‐T therapy: A phase I clinical study
8天前
已完结
Tumor-derived exosomes induce initial activation by exosomal CD19 antigen but impair the function of CD19-specific CAR T-cells via TGF-β signaling
8天前
已完结
CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations
8天前
已完结
Prognostic impact of peripheral eosinophil counts in patients with diffuse large B-cell lymphoma receiving chimeric antigen receptor T-cell therapy
8天前
已完结
Cytokines and signaling pathways involved in differentiation potential of hematopoietic stem cells towards natural killer cells
2个月前
已完结
Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China
2个月前
已完结
CAR T-cell therapy in autoimmune diseases
3个月前
已完结
Potential and pitfalls of repurposing the CAR-T cell regimen for the treatment of autoimmune disease
3个月前
已完结
Regional empowerment through decentralised governance under a centralised regulatory system facilitates the development of cellular therapy in China
4个月前
已完结
皖公网安备34019202002308
